We are live on
!
Find out more
SEM
Suncoast Equity Management Portfolio holdings
AUM
$833M
1-Year Est. Return
11.9%
This Fund
S&P 500
This Quarter
Est. Return
+12.46%
1 Year Est. Return
+11.9%
3 Year Est. Return
+72.94%
5 Year Est. Return
+102.95%
10 Year Est. Return
+465.47%
AUM
$789M
AUM Growth
+$73.9M
(+10%)
Cap. Flow
+$3.73M
Cap. Flow
% of AUM
0.47%
Top 10 Holdings %
Top 10 Hldgs %
66.39%
Holding
58
New
10
Increased
33
Reduced
8
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$15.6M |
| 2 |
Merck
MRK
|
+$11.8M |
| 3 |
KLA
KLAC
|
+$11.5M |
| 4 |
Advance Auto Parts
AAP
|
+$1.08M |
| 5 |
Accenture
ACN
|
+$829K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$25.1M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$10.4M |
| 3 |
Meta Platforms (Facebook)
META
|
+$8.45M |
| 4 |
Abbott
ABT
|
+$390K |
| 5 |
McDonald's
MCD
|
+$341K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 40.95% |
| 2 | Consumer Discretionary | 16.73% |
| 3 | Financials | 14.83% |
| 4 | Communication Services | 13.51% |
| 5 | Healthcare | 13.1% |
Similar funds
NWM
AWA
FM
IPAM
MAP
RAM
DLP
SCM
Suncoast Equity Management's Q4 2021 Portfolio in Review
As of Q4 2021, Suncoast Equity Management held 58 positions worth $789M, up 10% from $715M the previous quarter. Its ten largest holdings account for 66% of the portfolio.
Suncoast Equity Management's Q4 2021 filing shows 10 new, 33 increased, 8 reduced and 2 closed positions. Its largest new stake was KLA: 296,750 shares worth $12.8M. The largest sale was Regeneron Pharmaceuticals, an estimated $25.1M.
By sector, the portfolio is most concentrated in Technology at 41% of assets, up from 36% a quarter earlier, followed by Consumer Discretionary and Financials.
- Suncoast Equity Management's largest Q4 2021 buy was KLA: 296,750 shares worth $12.8M.
- Suncoast Equity Management added most to UnitedHealth in Q4 2021, an estimated $15.6M increase.
- Suncoast Equity Management's biggest Q4 2021 reduction was Berkshire Hathaway Class B, cutting an estimated $10.4M.
- Suncoast Equity Management fully exited Regeneron Pharmaceuticals in Q4 2021, selling an estimated $25.1M.
- Suncoast Equity Management's ten largest holdings make up 66% of its $789M portfolio in Q4 2021.
- Suncoast Equity Management opened 10 new positions and closed 2 in Q4 2021.
- Suncoast Equity Management's portfolio value rose 10% quarter-over-quarter to $789M.
Based on Suncoast Equity Management's 13F filing for Q4 2021, filed 28 Jan 2022.